To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RAD23BTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
349 representative clones for gene RAD23B back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB056450 testis .a 1 to 358 2 to 359   tiling clone, capped   358/358
(100 %)
0 diff
(100 %id)
DB051782 testis .a 2 to 292 2 to 292   capped   291/291
(100 %)
0 diff
(100 %id)
DB456820 testis .a 11 to 507 1 to 497       497/497
(100 %)
0 diff
(100 %id)
DB027197 testis .a 35 to 320 2 to 287   capped   286/286
(100 %)
0 diff
(100 %id)
DC384621   .a 89 to 638 1 to 550       550/550
(100 %)
0 diff
(100 %id)
CA866470 Pancreas, Purified pancreatic islet .a 108 to 702 11 to 605       595/626
(95 %)
12 diff
(98.1 %id)
NM_002874.3   .a 108 to 4237 1 to 4130 exact RefSeq,   4130/4130
(100 %)
0 diff
(100 %id)
AL540969 placenta .a 111 to 1219 1 to 1107       1107/1107
(100 %)
12 diff
(99.0 %id)
DA696622   .a 113 to 624 2 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
DA653141   .a 115 to 440 2 to 327   capped   326/326
(100 %)
0 diff
(100 %id)
DA907809   .a 115 to 933 2 to 828   capped   827/827
(100 %)
25 diff
(97.0 %id)
AL554483 placenta, Placenta Cot 25-normalized .a 117 to 1151 1 to 1032       1032/1037
(99 %)
14 diff
(98.7 %id)
AL532383 brain, fetal liver, Liver, neuroblastoma cells .a 117 to 1152 1 to 1032       1032/1035
(99 %)
16 diff
(98.5 %id)
DA027620   .a 119 to 387 2 to 270   capped   269/269
(100 %)
0 diff
(100 %id)
DA030643   .a 125 to 527 2 to 404   capped   403/403
(100 %)
0 diff
(100 %id)
DA441204 tongue, tumor tissue .a 125 to 454 2 to 331   capped   330/330
(100 %)
0 diff
(100 %id)
DA558159   .a 125 to 701 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB193236 ovary, tumor tissue .a 125 to 435 2 to 312   capped   311/311
(100 %)
0 diff
(100 %id)
AK223479 thymus .a 129 to 2379 1 to 2251 A221G A249V E371G     2251/2251
(100 %)
3 diff
(99.9 %id)
DA522798 brain .a 129 to 711 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
BP270966 small intestine .a 129 to 706 1 to 578       578/582
(99 %)
1 diff
(99.9 %id)
BP366631 thymus .a 129 to 709 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA032046   .a 130 to 698 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA390739 thalamus .a 130 to 714 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
AL571657 placenta, Placenta Cot 25-normalized .a 130 to 945 1 to 818       818/818
(100 %)
3 diff
(99.7 %id)
DA434491 tongue, tumor tissue .a 130 to 681 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA437516 tongue, tumor tissue .a 130 to 462 2 to 334   capped   333/333
(100 %)
0 diff
(100 %id)
DA480361   .a 130 to 479 2 to 351   capped   350/350
(100 %)
0 diff
(100 %id)
DA559254   .a 130 to 414 2 to 286   capped   285/285
(100 %)
0 diff
(100 %id)
DA712141   .a 130 to 674 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA787223 brain .a 130 to 688 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA878687 Prostate .a 130 to 688 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA557354   .a 133 to 682 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
AL549735 placenta, Placenta Cot 25-normalized .a 139 to 1156 1 to 1012       1012/1064
(95 %)
11 diff
(99.0 %id)
BQ927520 carcinoma, cell line, Prostate .a 139 to 974 1 to 840       840/885
(94 %)
10 diff
(98.9 %id)
CR606267 Placenta Cot 25-normalized .a 146 to 2201 1 to 2056 exact tiling clone,   2056/2056
(100 %)
0 diff
(100 %id)
AL544467 placenta, Placenta Cot 25-normalized .a 146 to 1156 1 to 1012       1012/1111
(91 %)
7 diff
(99.4 %id)
AL516156 brain, neuroblastoma, neuroblastoma cells .a 151 to 970 1 to 820       820/820
(100 %)
4 diff
(99.6 %id)
BM919879 pooled pancreas and spleen .a 153 to 1091 1 to 948       947/1008
(93 %)
53 diff
(94.8 %id)
D21090 cervical carcinoma .a 162 to 3066 1 to 2905 exact tiling clone,   2905/2905
(100 %)
3 diff
(99.9 %id)
DA506692 brain .a 175 to 694 2 to 521   capped   520/520
(100 %)
0 diff
(100 %id)
BX406219 fetal liver, Liver .a 242 to 1292 1 to 1041       1041/1041
(100 %)
15 diff
(98.6 %id)
BX344701   .a 250 to 1375 1 to 1117       1117/1117
(100 %)
20 diff
(98.3 %id)
BX385070   .a 250 to 1353 1 to 1092       1094/1123
(97 %)
27 diff
(97.6 %id)
BP374853 umbilical cord .a 412 to 994 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA022567   .a 413 to 978 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA273540 caudate nucleus .a 413 to 963 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB104073 thymus .a 413 to 961 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA026118   .a 433 to 988 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BG617563 Liver .a 452 to 1270 1 to 823       823/828
(99 %)
28 diff
(96.7 %id)
DA882544   .a 454 to 1026 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BC020973 Uterus, leiomyosarcoma .a 461 to 2488 37 to 2064 A249V available from MGC, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 2028/2028
(100 %)
1 diff
(100.0 %id)
DA881049   .a 470 to 1020 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
TI_1948077619   .a 474 to 1426 127 to 1071       945/1314
(71 %)
24 diff
(98.2 %id)
TI_1948077940   .a 474 to 1473 124 to 1120       997/1307
(76 %)
29 diff
(97.8 %id)
TI_1948078261   .a 474 to 1581 124 to 1222       1101/1343
(81 %)
48 diff
(96.5 %id)
TI_1948078590   .a 474 to 1294 125 to 949       825/1203
(68 %)
25 diff
(98.0 %id)
TI_1948078591   .a 474 to 1494 126 to 1157       1032/1311
(78 %)
45 diff
(96.6 %id)
CR609543 placenta .a 486 to 2159 1 to 1674       1674/1674
(100 %)
0 diff
(100 %id)
AL542437 placenta .a 486 to 1370 1 to 883   fully sequenced,   883/883
(100 %)
4 diff
(99.6 %id)
AA360579   .a 499 to 732 1 to 234       234/234
(100 %)
0 diff
(100 %id)
AW631016 2 pooled high-grade transitional celltumors, genitourinary tract .a 525 to 1035 1 to 511       511/511
(100 %)
0 diff
(100 %id)
CX753103 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 532 to 1275 1 to 737     Submitted on the opposite strand 737/837
(88 %)
12 diff
(98.6 %id)
DA823294 pericardium .a 598 to 1054 2 to 458   capped   457/457
(100 %)
0 diff
(100 %id)
DA559173   .a 609 to 1163 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA709783   .a 612 to 1163 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
AU135170 placenta .a 646 to 1347 2 to 710   capped   707/755
(93 %)
10 diff
(98.7 %id)
AW629978 2 pooled high-grade transitional celltumors, genitourinary tract .a 655 to 1179 34 to 558     Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 525/558
(94 %)
10 diff
(98.3 %id)
BU508207 leiomyosarcoma, uterus .a 676 to 1574 1 to 906       906/907
(99 %)
24 diff
(97.4 %id)
BM846302 myeloma .a 700 to 1305 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BM785167 myeloma .a 700 to 1338 1 to 639       639/639
(100 %)
0 diff
(100 %id)
TI_1948077620   .a 703 to 1714 1121 to 120       1002/1275
(78 %)
28 diff
(97.9 %id)
TI_1948077941   .a 703 to 1714 1128 to 119       1010/1293
(78 %)
17 diff
(98.7 %id)
TI_1948078592   .a 703 to 1714 1130 to 118       1013/1329
(76 %)
36 diff
(97.3 %id)
CN414101 embryonic stem cells, cell lines H1, H7, andH9 .a 715 to 1382 1 to 668       668/668
(100 %)
0 diff
(100 %id)
TI_1948078262   .a 778 to 1714 1053 to 119       935/1271
(73 %)
19 diff
(98.6 %id)
EC489649 Prostate .a 855 to 934 80 to 1       80/80
(100 %)
0 diff
(100 %id)
BM705797 eye, lens .a 893 to 1311 1 to 419     Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 419/419
(100 %)
0 diff
(100 %id)
DB254065 uterus .a 1003 to 1488 2 to 487   capped   486/486
(100 %)
0 diff
(100 %id)
DA439748 tongue, tumor tissue .a 1049 to 1608 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BG681545 skin, squamous cell carcinoma .a 1068 to 1917 1 to 858       858/879
(97 %)
17 diff
(98.1 %id)
AA460535   .a 1089 to 1579 1 to 490     Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 490/490
(100 %)
3 diff
(99.4 %id)
AL570682 placenta, Placenta Cot 25-normalized .a 1139 to 2201 1060 to 1       1060/1150
(92 %)
10 diff
(99.2 %id)
CN414100 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1247 to 1812 1 to 566       566/566
(100 %)
0 diff
(100 %id)
BX411441 fetal liver, Liver .a 1283 to 2128 847 to 1       847/941
(90 %)
14 diff
(98.6 %id)
AL569427 placenta .a 1340 to 2159 820 to 1   fully sequenced,   820/820
(100 %)
17 diff
(98.0 %id)
BX406218 fetal liver, Liver .a 1410 to 2454 1044 to 8       1037/1049
(98 %)
24 diff
(97.8 %id)
BF795639 lymph, lymphoma, cell line .a 1422 to 2154 1 to 729       729/974
(74 %)
15 diff
(98.5 %id)
M85669   .a 1427 to 1819 1 to 393       393/393
(100 %)
0 diff
(100 %id)
CR985525 T-Lymphocytes .a 1450 to 2272 1 to 823       823/825
(99 %)
4 diff
(99.6 %id)
BX383940   .a 1456 to 2462 1004 to 1       1004/1017
(98 %)
14 diff
(98.7 %id)
AA460124   .a 1483 to 2077 5 to 599     Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 595/599
(99 %)
6 diff
(99.0 %id)
CD107198 brain, Pituitary .a 1518 to 2329 1 to 823       823/850
(96 %)
12 diff
(98.6 %id)
AL573931 placenta, Placenta Cot 25-normalized .a 1533 to 2465 932 to 1       932/1038
(89 %)
24 diff
(97.7 %id)
CX783555 human embryonic stem cells .a 1577 to 1841 1 to 265       265/265
(100 %)
0 diff
(100 %id)
CB270615 adipose .a 1589 to 1889 1 to 301       301/301
(100 %)
0 diff
(100 %id)
BX374094   .a 1589 to 2440 891 to 43       849/891
(95 %)
12 diff
(98.7 %id)
AL571656 placenta, Placenta Cot 25-normalized .a 1606 to 2465 869 to 10       860/869
(98 %)
0 diff
(100 %id)
CN414110 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1608 to 2190 1 to 583       583/583
(100 %)
0 diff
(100 %id)
AL516155 brain, neuroblastoma, neuroblastoma cells .a 1612 to 2483 870 to 1       870/873
(99 %)
38 diff
(95.7 %id)
BU183269 melanotic melanoma, skin .a 1615 to 2475 1 to 872       872/877
(99 %)
20 diff
(97.8 %id)
TI_227714110   .a 1643 to 2496 938 to 94   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 845/961
(87 %)
12 diff
(98.8 %id)
TI_154107259   .a 1663 to 2493 914 to 89   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 826/947
(87 %)
9 diff
(99.1 %id)
TI_154107249   .a 1667 to 2493 908 to 89   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 820/960
(85 %)
25 diff
(97.4 %id)
TI_154107260   .a 1713 to 2493 862 to 90   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 773/920
(84 %)
9 diff
(99.1 %id)
CR622837 Neuroblastoma Cot 25-normalized .a 1761 to 2879 1 to 1119       1119/1119
(100 %)
0 diff
(100 %id)
AL527365 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1761 to 2462 1 to 700   fully sequenced,   700/700
(100 %)
2 diff
(99.8 %id)
AL568670 placenta .a 1779 to 2784 1140 to 131       1010/1010
(100 %)
14 diff
(98.7 %id)
BX344700   .a 1803 to 2901 1090 to 1       1090/1094
(99 %)
18 diff
(98.4 %id)
BI598290 brain, hypothalamus .a 1836 to 2655 1 to 829       829/832
(99 %)
23 diff
(97.3 %id)
TI_45211018   .a 1839 to 2655 83 to 908       826/911
(90 %)
23 diff
(97.5 %id)
CD364834 Alveolar Macrophage, lung .a 1845 to 2496 667 to 16   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 652/652
(100 %)
0 diff
(100 %id)
CA447019 Chondrosarcoma, Left Pubic Bone .a 1847 to 2493 660 to 14   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 647/647
(100 %)
0 diff
(100 %id)
CA447020 Chondrosarcoma, Left Pubic Bone .a 1847 to 2493 660 to 14   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 647/647
(100 %)
0 diff
(100 %id)
CR736568 melanocyte .a 1852 to 2564 1 to 714       714/714
(100 %)
3 diff
(99.6 %id)
BU182095 eye, retinoblastoma .a 1853 to 2720 21 to 892       872/893
(97 %)
10 diff
(98.9 %id)
CN414109 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1854 to 2198 1 to 345       345/345
(100 %)
0 diff
(100 %id)
CN414105 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1856 to 2399 1 to 544       544/544
(100 %)
0 diff
(100 %id)
EC466185 Prostate .a 1856 to 1948 1 to 93       93/93
(100 %)
0 diff
(100 %id)
CX788751 human embryonic stem cells .a 1856 to 2616 1 to 761       761/761
(100 %)
0 diff
(100 %id)
BU517069 leiomyosarcoma, uterus .a 1857 to 2720 1 to 867       867/870
(99 %)
4 diff
(99.6 %id)
BE018541 cervix .a 1863 to 2306 1 to 444       444/444
(100 %)
0 diff
(100 %id)
AA304988 colon .a 1865 to 2211 1 to 347       347/347
(100 %)
0 diff
(100 %id)
AL532382 brain, fetal liver, Liver, neuroblastoma cells .a 1914 to 2870 978 to 26       953/1016
(93 %)
0 diff
(100 %id)
BM758143 stomach .a 1920 to 2396 1 to 477       477/477
(100 %)
0 diff
(100 %id)
AU119295 whole embryo, mainly head .a 1952 to 2804 2 to 855   capped   854/854
(100 %)
5 diff
(99.5 %id)
DB331309   .a 1958 to 2488 537 to 1       537/539
(99 %)
9 diff
(98.4 %id)
BG987969 head_neck .a 1963 to 2352 422 to 33       390/422
(92 %)
0 diff
(100 %id)
AL577167 placenta, Placenta Cot 25-normalized .a 1978 to 3030 1051 to 1       1051/1051
(100 %)
26 diff
(97.6 %id)
AU155865 placenta .a 2001 to 2493 495 to 1       495/495
(100 %)
9 diff
(98.2 %id)
AW885819 ovary .a 2006 to 2257 251 to 1       251/265
(94 %)
15 diff
(94.4 %id)
BP291611 lung .a 2011 to 2593 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BX339394 Placenta Cot 25-normalized .a 2037 to 3055 1004 to 1       1004/1032
(97 %)
22 diff
(97.9 %id)
AI626128 colon .a 2043 to 2488 446 to 1       446/446
(100 %)
0 diff
(100 %id)
TI_149315264   .a 2062 to 2940 954 to 84   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 871/964
(90 %)
17 diff
(98.3 %id)
BX366843 Placenta Cot 25-normalized .a 2084 to 3028 941 to 1       941/941
(100 %)
29 diff
(97.0 %id)
AA480330 colon .a 2087 to 2496 420 to 11   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 410/410
(100 %)
0 diff
(100 %id)
AA687552   .a 2095 to 2496 415 to 14       402/415
(96 %)
0 diff
(100 %id)
AW132114 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2103 to 2497 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AW614946 2 pooled high-grade transitional celltumors, genitourinary tract .a 2104 to 2496 403 to 11   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 393/393
(100 %)
0 diff
(100 %id)
AL121484 melanoma (MeWo cell line) .a 2124 to 2484 1 to 361       361/361
(100 %)
0 diff
(100 %id)
C04572 heart .a 2166 to 2491 1 to 326       326/326
(100 %)
0 diff
(100 %id)
BQ006361 Chondrosarcoma, Left Pelvis .a 2202 to 2934 750 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 732/732
(100 %)
1 diff
(99.9 %id)
BQ000373 Fibrosarcoma .a 2289 to 2940 670 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 652/652
(100 %)
0 diff
(100 %id)
BY796776 eye .a 2302 to 2881 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BU155781 melanotic melanoma, skin .a 2305 to 2941 1 to 637       637/912
(69 %)
1 diff
(99.9 %id)
BM697549 eye, fetal eyes .a 2315 to 2923 1 to 610   fully sequenced, Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 610/610
(100 %)
0 diff
(100 %id)
N44512 melanocyte .a 2326 to 2523 1 to 198   fully sequenced,   198/198
(100 %)
0 diff
(100 %id)
DN913012   .a 2332 to 2940 608 to 1       608/608
(100 %)
3 diff
(99.6 %id)
CB240875 Human Lung Epithelial cells, lung .a 2332 to 2934 621 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 603/612
(98 %)
0 diff
(100 %id)
N36434 melanocyte .a 2335 to 2607 1 to 273       273/273
(100 %)
0 diff
(100 %id)
AA393532.
matches multiple genes
  .a 2335 to 2752 1 to 418     also hits gene HAUS1 418/418
(100 %)
0 diff
(100 %id)
BM451113 eye, retinoblastoma .a 2350 to 3261 1 to 919       919/919
(100 %)
7 diff
(99.3 %id)
N48034 melanocyte .a 2366 to 2547 1 to 183   fully sequenced,   183/183
(100 %)
0 diff
(100 %id)
DN917502   .a 2387 to 2940 550 to 1       550/551
(99 %)
4 diff
(99.3 %id)
DN918108   .a 2387 to 2934 547 to 1       547/582
(93 %)
3 diff
(99.5 %id)
AW299682 Kidney .a 2389 to 2940 552 to 1       552/552
(100 %)
0 diff
(100 %id)
DN913459   .a 2394 to 2591 1 to 198       198/198
(100 %)
0 diff
(100 %id)
DN918950   .a 2394 to 2730 1 to 337       337/337
(100 %)
0 diff
(100 %id)
TI_149304391   .a 2405 to 2923 62 to 582     Submitted on the opposite strand 521/1081
(48 %)
5 diff
(99.6 %id)
BU685320 lung, Primary Lung Epithelial Cells .a 2408 to 2923 1 to 517   AAA Submitted on the opposite strand 517/525
(98 %)
2 diff
(99.7 %id)
AI677733 colon .a 2424 to 2807 384 to 1       384/384
(100 %)
0 diff
(100 %id)
CA844250 Pancreas, Purified pancreatic islet .a 2425 to 2941 519 to 3       517/519
(99 %)
0 diff
(100 %id)
DN916101   .a 2427 to 2940 510 to 1       510/510
(100 %)
8 diff
(98.5 %id)
AL527314 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 2432 to 2879 448 to 1   fully sequenced,   448/448
(100 %)
2 diff
(99.6 %id)
AI651048 Kidney .a 2433 to 2940 508 to 1       508/508
(100 %)
0 diff
(100 %id)
FN093209 breast carcinoma .a 2455 to 2561 104 to 1     Submitted on the opposite strand 104/111
(93 %)
3 diff
(97.3 %id)
DB543207 hippocampus .a 2464 to 2940 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
AA461479   .a 2468 to 2940 487 to 15   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 473/473
(100 %)
1 diff
(99.8 %id)
AA442401   .a 2476 to 2886 1 to 411       411/411
(100 %)
0 diff
(100 %id)
AI954584 malignant melanoma, metastatic to lymphnode, skin .a 2476 to 2621 146 to 1       146/146
(100 %)
0 diff
(100 %id)
AU125295   .a 2480 to 3352 2 to 873   capped   872/872
(100 %)
6 diff
(99.4 %id)
FN149634 breast carcinoma .a 2484 to 2586 112 to 12     Submitted on the opposite strand 101/112
(90 %)
0 diff
(100 %id)
FN125708 breast carcinoma .a 2486 to 2571 90 to 1     Submitted on the opposite strand 90/91
(98 %)
5 diff
(94.6 %id)
AA287582 germinal center B cell .a 2489 to 2940 469 to 18   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 452/452
(100 %)
0 diff
(100 %id)
N34788 melanocyte .a 2493 to 2940 450 to 1   fully sequenced,   450/450
(100 %)
1 diff
(99.8 %id)
AI446146 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2496 to 2621 126 to 1       126/126
(100 %)
0 diff
(100 %id)
DN918642   .a 2497 to 2940 445 to 1       445/445
(100 %)
5 diff
(98.9 %id)
AI186288 placenta .a 2498 to 2941 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AW076014 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 2498 to 2621 124 to 1       124/124
(100 %)
0 diff
(100 %id)
FN141996 breast carcinoma .a 2501 to 2604 99 to 1     Submitted on the opposite strand 99/99
(100 %)
4 diff
(96.0 %id)
BG678535 skin, squamous cell carcinoma .a 2515 to 3385 1 to 868       868/946
(91 %)
22 diff
(97.7 %id)
N35399 melanocyte .a 2517 to 2940 423 to 1   fully sequenced,   423/423
(100 %)
1 diff
(99.8 %id)
AA279208 germinal center B cell .a 2527 to 2940 431 to 18   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 414/414
(100 %)
0 diff
(100 %id)
AA768773 germinal center B cell .a 2531 to 2940 435 to 26   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 410/410
(100 %)
0 diff
(100 %id)
BE676865 B-cell, chronic lymphotic leukemia .a 2538 to 2941 404 to 1       404/404
(100 %)
0 diff
(100 %id)
FN104872 breast carcinoma .a 2540 to 2641 1 to 102       102/102
(100 %)
0 diff
(100 %id)
AA934659 pooled germ cell tumors .a 2549 to 2940 392 to 1       392/392
(100 %)
0 diff
(100 %id)
BM695387 eye, optic nerve .a 2556 to 3280 1 to 727     Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 727/727
(100 %)
2 diff
(99.8 %id)
FN089866 breast carcinoma .a 2565 to 2665 96 to 1     Submitted on the opposite strand 96/96
(100 %)
5 diff
(94.8 %id)
AA513365 colon .a 2583 to 2934 352 to 1       352/352
(100 %)
0 diff
(100 %id)
DN913458   .a 2587 to 2941 360 to 6       355/360
(98 %)
0 diff
(100 %id)
BQ002122 Chondrosarcoma, Left Pelvis .a 2592 to 3089 512 to 15   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 498/498
(100 %)
0 diff
(100 %id)
FN146532 breast carcinoma .a 2593 to 2697 106 to 5     Submitted on the opposite strand 102/106
(96 %)
0 diff
(100 %id)
AA584255 colon, colon tumor RER+ .a 2599 to 2934 336 to 1       336/336
(100 %)
0 diff
(100 %id)
AA482857 alveolar rhabdomyosarcoma .a 2600 to 2941 353 to 12       342/353
(96 %)
0 diff
(100 %id)
TI_154138748   .a 2602 to 3095 81 to 574       494/494
(100 %)
0 diff
(100 %id)
FN165791 breast carcinoma .a 2617 to 2724 109 to 1     Submitted on the opposite strand 109/109
(100 %)
1 diff
(99.1 %id)
F36947 pectoral muscle (after mastectomy) .a 2623 to 2887 1 to 265       265/265
(100 %)
0 diff
(100 %id)
F36950 pectoral muscle (after mastectomy) .a 2626 to 2881 1 to 256       256/256
(100 %)
0 diff
(100 %id)
AW978671   .a 2636 to 3099 465 to 1     Submitted on the opposite strand 465/471
(98 %)
10 diff
(97.9 %id)
AA460536   .a 2637 to 3093 471 to 15   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 457/457
(100 %)
0 diff
(100 %id)
AW264174 brain, three pooled meningiomas .a 2639 to 2940 302 to 1       302/302
(100 %)
0 diff
(100 %id)
BE302137 cervix .a 2639 to 2941 303 to 1       303/303
(100 %)
0 diff
(100 %id)
BE464810 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 2639 to 3093 455 to 1       455/455
(100 %)
0 diff
(100 %id)
CN414114 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2640 to 3089 464 to 13     Submitted on the opposite strand 452/464
(97 %)
0 diff
(100 %id)
DN916974   .a 2640 to 2940 301 to 1       301/303
(99 %)
14 diff
(95.4 %id)
T05992   .a 2665 to 2930 269 to 1       269/270
(99 %)
4 diff
(98.6 %id)
FN126907 breast carcinoma .a 2709 to 2820 112 to 1     Submitted on the opposite strand 112/112
(100 %)
7 diff
(93.8 %id)
DN919025   .a 2711 to 2935 228 to 5       224/228
(98 %)
0 diff
(100 %id)
FN083243 breast carcinoma .a 2711 to 2823 114 to 1     Submitted on the opposite strand 114/115
(99 %)
1 diff
(99.2 %id)
FN127170 breast carcinoma .a 2722 to 2803 82 to 1     Submitted on the opposite strand 82/89
(92 %)
2 diff
(97.8 %id)
FN057576 breast carcinoma .a 2741 to 2849 109 to 1     Submitted on the opposite strand 109/109
(100 %)
0 diff
(100 %id)
AA831726 germinal center B cell .a 2778 to 3100 343 to 21   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 323/323
(100 %)
0 diff
(100 %id)
DN914958   .a 2779 to 3100 322 to 1       322/322
(100 %)
1 diff
(99.7 %id)
FN073426 breast carcinoma .a 2790 to 2873 82 to 1     Submitted on the opposite strand 82/83
(98 %)
2 diff
(97.6 %id)
AA629089   .a 2798 to 2940 143 to 1       143/143
(100 %)
0 diff
(100 %id)
FN116803 breast carcinoma .a 2813 to 2914 105 to 1     Submitted on the opposite strand 105/105
(100 %)
3 diff
(97.2 %id)
EC486115 Prostate .a 2828 to 2931 109 to 6       104/109
(95 %)
0 diff
(100 %id)
T10859   .a 2856 to 3092 239 to 4     Submitted on the opposite strand 236/239
(98 %)
0 diff
(100 %id)
FN176917 breast carcinoma .a 2868 to 2939 75 to 3     Submitted on the opposite strand 73/75
(97 %)
0 diff
(100 %id)
BU735736 eye, fetal eyes .a 2893 to 3093 219 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 201/201
(100 %)
1 diff
(99.6 %id)
EH345990   .a 2910 to 3005 1 to 96       96/96
(100 %)
0 diff
(100 %id)
CX752287 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2910 to 3696 1 to 776   tiling clone, Submitted on the opposite strand 776/821
(94 %)
13 diff
(98.5 %id)
AI151490 placenta .a 3162 to 3610 449 to 1       449/449
(100 %)
0 diff
(100 %id)
CR592064 Neuroblastoma Cot 25-normalized .a 3212 to 4208 1 to 997   tiling clone,   997/997
(100 %)
0 diff
(100 %id)
AI338185 lung .a 3258 to 3736 479 to 1       479/479
(100 %)
0 diff
(100 %id)
TI_149312167   .a 3374 to 4236 942 to 88   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 855/995
(85 %)
13 diff
(98.7 %id)
AA393646   .a 3483 to 3941 1 to 458   fully sequenced,   458/458
(100 %)
2 diff
(99.6 %id)
BM665033 eye, optic nerve .a 3600 to 4239 657 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 639/639
(100 %)
1 diff
(99.9 %id)
DB362967   .a 3688 to 4236 545 to 1       545/545
(100 %)
12 diff
(97.8 %id)
BU734993 eye, lens .a 3886 to 4236 367 to 17   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 351/351
(100 %)
0 diff
(100 %id)
AA400831   .a 3911 to 4236 326 to 1   fully sequenced,   326/326
(100 %)
0 diff
(100 %id)
AK293532 cerebellum .b 1 to 1811 1 to 1811 exact tiling clone,   1811/1811
(100 %)
2 diff
(99.9 %id)
DC303220 cerebellum .b 1 to 503 1 to 503       503/503
(100 %)
2 diff
(99.7 %id)
DA775935 brain .b 11 to 299 2 to 290   capped   289/289
(100 %)
2 diff
(99.4 %id)
DC303593 cerebellum .b 12 to 592 1 to 581       581/581
(100 %)
0 diff
(100 %id)
AL119925 amygdala .b 16 to 379 1 to 364       364/364
(100 %)
0 diff
(100 %id)
F29630 pectoral muscle (after mastectomy) .b 1429 to 1716 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
F37059 pectoral muscle (after mastectomy) .b 1437 to 1763 1 to 327       327/327
(100 %)
1 diff
(99.7 %id)
F31066 pectoral muscle (after mastectomy) .b 1462 to 1790 1 to 329       329/329
(100 %)
3 diff
(99.1 %id)
BG718045 testis .c 1 to 572 1 to 571   tiling clone,   571/571
(100 %)
4 diff
(99.3 %id)
BI460482 testis .c 1 to 688 1 to 687       687/687
(100 %)
4 diff
(99.5 %id)
DA557773   .c 46 to 591 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
AK297986   .c 49 to 1421 1 to 1373 exact tiling clone,   1373/1373
(100 %)
1 diff
(100.0 %id)
DC358095   .c 49 to 605 1 to 558       558/558
(100 %)
2 diff
(99.7 %id)
AK316189   .c 94 to 1430 1 to 1337 N372R     1337/1337
(100 %)
2 diff
(99.9 %id)
DA580904   .c 95 to 662 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB522251 testis .c 982 to 1443 1 to 462   tiling clone, Submitted on the opposite strand 462/462
(100 %)
0 diff
(100 %id)
AY313777 testis .d 1 to 1527 1 to 1527 A177V tiling clone, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 1527/1527
(100 %)
2 diff
(99.9 %id)
TI_44159989   .e 1 to 699 66 to 764   tiling clone,   699/764
(91 %)
6 diff
(99.3 %id)
BQ929186 epidermoid carcinoma, cell line, lung .e 512 to 1335 1 to 825   tiling clone,   825/932
(88 %)
8 diff
(99.2 %id)
TI_151731669   .e 796 to 1321 605 to 80   tiling clone, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 526/952
(55 %)
3 diff
(99.7 %id)
BQ189387 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 802 to 1321 1 to 520   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 520/520
(100 %)
0 diff
(100 %id)
BG114421 Bone, osteosarcoma, cell line .e 822 to 1321 1 to 511   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 511/511
(100 %)
20 diff
(96.1 %id)
BG927123 cartilage .e 824 to 1321 90 to 587   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 498/516
(96 %)
6 diff
(98.9 %id)
AI768348 pooled .e 836 to 1322 494 to 7       488/494
(98 %)
0 diff
(100 %id)
AW055317 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 840 to 1321 484 to 1       484/484
(100 %)
3 diff
(99.4 %id)
AI375313   .e 893 to 1327 441 to 6   tiling clone,   436/441
(98 %)
0 diff
(100 %id)
AW152634 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 893 to 1327 444 to 10       435/444
(97 %)
0 diff
(100 %id)
AW886446 ovary .e 901 to 1285 388 to 5       384/392
(97 %)
0 diff
(100 %id)
AI245817 Kidney .e 902 to 1321 419 to 1       419/419
(100 %)
1 diff
(99.8 %id)
BF096117 uterus_tumor .e 919 to 1249 336 to 8       329/350
(94 %)
0 diff
(100 %id)
BF096223 uterus_tumor .e 921 to 1249 335 to 8       328/335
(97 %)
0 diff
(100 %id)
CD521100 pooled .e 924 to 1321 1 to 398       398/399
(99 %)
2 diff
(99.5 %id)
AA907278 carcinoid, lung .e 926 to 1320 395 to 1       395/395
(100 %)
3 diff
(99.3 %id)
AI285544 lymph node, mantle cell lymphoma .e 939 to 1322 384 to 1       384/384
(100 %)
0 diff
(100 %id)
BQ188236 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 941 to 1321 1 to 381   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 381/381
(100 %)
0 diff
(100 %id)
AI888970 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1010 to 1327 331 to 14       318/331
(96 %)
0 diff
(100 %id)
AA614164   .e 1014 to 1325 8 to 319   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 312/319
(97 %)
6 diff
(98.2 %id)
BE927636 colon .e 1023 to 1272 12 to 258       247/258
(95 %)
6 diff
(97.7 %id)
BQ022617 placenta .e 1026 to 1325 319 to 20   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 300/300
(100 %)
1 diff
(99.7 %id)
AI888977 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1050 to 1321 291 to 20   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 272/272
(100 %)
1 diff
(99.7 %id)
CA433382 mixed .e 1079 to 1321 259 to 17   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 243/243
(100 %)
1 diff
(99.6 %id)
AI208206   .e 1084 to 1327 265 to 22       244/265
(92 %)
0 diff
(100 %id)
BF477805 Prostate .e 1097 to 1321 225 to 1       225/225
(100 %)
0 diff
(100 %id)
BF222776 Prostate .e 1099 to 1321 223 to 1       223/223
(100 %)
0 diff
(100 %id)
CA337139 posterior rhombomeres 5-8 (4 pooled) .e 1124 to 1325 1 to 202   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 202/202
(100 %)
0 diff
(100 %id)
DA292511 hippocampus .f 1 to 563 11 to 577   tiling clone, capped   567/576
(98 %)
11 diff
(98.1 %id)
DA557273   .f 40 to 584 2 to 546   tiling clone, capped   545/545
(100 %)
0 diff
(100 %id)
BF949974 nervous_normal .f 54 to 635 601 to 18 T15Y T16N Q17S Q18A S19V ... tiling clone,   584/603
(96 %)
6 diff
(99.1 %id)
BM845855 myeloma .f 80 to 550 1 to 471       471/471
(100 %)
0 diff
(100 %id)
CD652770 Embryonic Stem cells .g-u 1 to 736 4 to 734 exact tiling clone,   731/787
(92 %)
14 diff
(98.3 %id)
CB156847 Liver .g-u 618 to 1235 1 to 618   tiling clone,   618/618
(100 %)
0 diff
(100 %id)
BX483047   .g-u 932 to 1586 18 to 672   tiling clone,   655/672
(97 %)
6 diff
(99.2 %id)
AI538438 B-cell, chronic lymphotic leukemia .h-u 1 to 469 469 to 1 exact tiling clone,   469/469
(100 %)
0 diff
(100 %id)
AA086258 muscle, skeletal muscle .h-u 36 to 429 395 to 1 exact     395/404
(97 %)
2 diff
(99.6 %id)
AI383110 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h-u 167 to 467 301 to 1 exact     301/301
(100 %)
0 diff
(100 %id)
BM556178 duodenal adenocarcinoma, cell line, small intestine .h-u 172 to 1044 1 to 876 exact tiling clone,   876/1059
(82 %)
41 diff
(96.2 %id)
BE817834 breast_normal .h-u 193 to 464 1 to 272       272/283
(96 %)
4 diff
(98.6 %id)
BI058211 placenta_normal .h-u 193 to 655 491 to 28       464/501
(92 %)
0 diff
(100 %id)
DW423368 Liver .h-u 860 to 1135 17 to 292   tiling clone,   276/292
(94 %)
6 diff
(98.0 %id)
AA366150 Pancreas .h-u 899 to 1149 1 to 252       252/262
(96 %)
3 diff
(98.9 %id)
DW441366 Liver .h-u 1070 to 1290 18 to 238   tiling clone,   221/238
(92 %)
6 diff
(97.5 %id)
N77275 liver and spleen .i-u 1 to 440 1 to 443   tiling clone,   443/443
(100 %)
11 diff
(97.6 %id)
T93175 lung .i-u 281 to 623 1 to 347       347/347
(100 %)
14 diff
(96.0 %id)
AI820558 lung .i-u 282 to 834 1 to 550       550/550
(100 %)
4 diff
(99.3 %id)
T94216 lung .i-u 282 to 695 1 to 423       423/423
(100 %)
15 diff
(96.5 %id)
T71918 lung .i-u 283 to 481 1 to 202       202/207
(97 %)
7 diff
(96.7 %id)
T87917 lung .i-u 283 to 651 1 to 369       369/371
(99 %)
6 diff
(98.4 %id)
T93698 lung .i-u 283 to 597 1 to 316       316/320
(98 %)
11 diff
(96.6 %id)
T93713 lung .i-u 283 to 583 1 to 303   tiling clone,   303/325
(93 %)
5 diff
(98.5 %id)
T93501 lung .i-u 283 to 589 1 to 308       308/317
(97 %)
10 diff
(96.9 %id)
T93761 lung .i-u 283 to 661 1 to 386       386/389
(99 %)
17 diff
(95.7 %id)
T89807 lung .i-u 283 to 678 1 to 397   fully sequenced,   397/397
(100 %)
9 diff
(97.8 %id)
T89926 lung .i-u 283 to 668 1 to 386       386/543
(71 %)
8 diff
(98.6 %id)
T89221 lung .i-u 283 to 766 1 to 490       490/492
(99 %)
21 diff
(95.8 %id)
T89236 lung .i-u 283 to 753 1 to 474   tiling clone, fully sequenced,   474/474
(100 %)
16 diff
(96.7 %id)
T93539 lung .i-u 283 to 717 1 to 442   fully sequenced,   442/442
(100 %)
17 diff
(96.2 %id)
T90582 lung .i-u 283 to 619 1 to 341       341/343
(99 %)
12 diff
(96.6 %id)
T90607 lung .i-u 283 to 695 1 to 424   fully sequenced,   424/424
(100 %)
19 diff
(95.6 %id)
T90397 lung .i-u 283 to 677 1 to 405       405/406
(99 %)
16 diff
(96.1 %id)
T90428 lung .i-u 283 to 671 1 to 393       393/398
(98 %)
11 diff
(97.3 %id)
T92135 lung .i-u 283 to 625 1 to 351   fully sequenced,   351/351
(100 %)
13 diff
(96.3 %id)
T92160 lung .i-u 283 to 677 1 to 404   tiling clone,   404/415
(97 %)
14 diff
(96.7 %id)
T92290 lung .i-u 283 to 668 1 to 397       397/416
(95 %)
22 diff
(94.8 %id)
T92305 lung .i-u 283 to 580 1 to 303       303/430
(70 %)
9 diff
(98.0 %id)
T91478 lung .i-u 283 to 515 1 to 236       236/241
(97 %)
7 diff
(97.1 %id)
T91480 lung .i-u 283 to 579 1 to 312       312/314
(99 %)
22 diff
(93.0 %id)
T92380 lung .i-u 283 to 694 1 to 413   fully sequenced,   413/413
(100 %)
6 diff
(98.6 %id)
T92395 lung .i-u 283 to 694 1 to 412   fully sequenced,   412/412
(100 %)
5 diff
(98.8 %id)
T92409 lung .i-u 283 to 656 1 to 378       378/381
(99 %)
11 diff
(97.2 %id)
T91550 lung .i-u 283 to 671 1 to 396   fully sequenced,   396/396
(100 %)
16 diff
(96.0 %id)
T92621 lung .i-u 283 to 658 1 to 379   fully sequenced,   379/379
(100 %)
12 diff
(96.9 %id)
T92632 lung .i-u 283 to 706 1 to 432       432/432
(100 %)
17 diff
(96.1 %id)
T92993.
matches multiple genes
lung .i-u 283 to 651 1 to 377     also hits gene SFTPA1 377/378
(99 %)
19 diff
(95.0 %id)
T92820 lung .i-u 283 to 677 1 to 399       399/400
(99 %)
13 diff
(96.8 %id)
T92999 lung .i-u 283 to 651 1 to 383       383/386
(99 %)
18 diff
(95.4 %id)
T93009.
matches multiple genes
lung .i-u 283 to 651 1 to 387     also hits gene PRKCDBP 387/445
(86 %)
22 diff
(95.1 %id)
T91692 lung .i-u 283 to 744 1 to 476       476/479
(99 %)
24 diff
(95.0 %id)
T92667 lung .i-u 283 to 665 1 to 389       389/403
(96 %)
16 diff
(96.1 %id)
T92866 lung .i-u 283 to 706 1 to 431       431/431
(100 %)
16 diff
(96.3 %id)
T93050 lung .i-u 283 to 670 1 to 395       395/397
(99 %)
20 diff
(95.0 %id)
T94154 lung .i-u 283 to 677 1 to 396       396/397
(99 %)
7 diff
(98.3 %id)
T94266 lung .i-u 283 to 695 1 to 424   fully sequenced,   424/424
(100 %)
16 diff
(96.3 %id)
T94035 lung .i-u 283 to 696 1 to 422       422/422
(100 %)
16 diff
(96.3 %id)
T94054 lung .i-u 283 to 662 1 to 384       384/426
(90 %)
10 diff
(97.7 %id)
T96475 lung .i-u 283 to 672 1 to 400   fully sequenced,   400/400
(100 %)
22 diff
(94.5 %id)
T96479 lung .i-u 283 to 664 1 to 387   fully sequenced,   387/387
(100 %)
14 diff
(96.4 %id)
T94491 lung .i-u 283 to 627 1 to 349       349/434
(80 %)
11 diff
(97.5 %id)
T94502 lung .i-u 283 to 665 1 to 390       390/398
(97 %)
16 diff
(96.0 %id)
T94463 lung .i-u 284 to 651 1 to 369       369/373
(98 %)
8 diff
(97.9 %id)
T94231 lung .i-u 286 to 651 1 to 371       371/404
(91 %)
11 diff
(97.3 %id)
T90401 lung .i-u 307 to 651 1 to 348       348/389
(89 %)
9 diff
(97.7 %id)
T98233 lung .i-u 328 to 671 1 to 355       355/376
(94 %)
18 diff
(95.3 %id)
T93193 lung .i-u 335 to 611 1 to 274       274/274
(100 %)
5 diff
(98.2 %id)
T93237.
matches multiple genes
lung .i-u 335 to 677 1 to 342     also hits gene fleejerbu 342/343
(99 %)
8 diff
(97.7 %id)
T93043 lung .i-u 336 to 659 1 to 329       329/368
(89 %)
15 diff
(96.0 %id)
T92492 lung .i-u 341 to 626 1 to 290       290/319
(90 %)
12 diff
(96.3 %id)
T94023 lung .i-u 358 to 659 1 to 305       305/368
(82 %)
9 diff
(97.6 %id)
T90412 lung .i-u 366 to 696 1 to 339       339/341
(99 %)
13 diff
(96.2 %id)
AI821397 lung .i-u 565 to 1024 470 to 13 exact tiling clone, AAA   458/458
(100 %)
1 diff
(99.8 %id)
T92933 lung .i-u 583 to 1034 468 to 3 I2L F3N F4D S5F L6F ...     466/504
(92 %)
0 diff
(100 %id)
T93562 lung .i-u 595 to 1036 452 to 1 I2L F3N F4D S5F L6F ... fully sequenced,   452/452
(100 %)
18 diff
(96.1 %id)
T96389 lung .i-u 602 to 1018 439 to 2 I2N F3G F4P S5K L6W ... fully sequenced,   438/439
(99 %)
0 diff
(100 %id)
T93520 lung .i-u 619 to 1019 419 to 8 I2K F3W F4I S5F L6F ...     412/419
(98 %)
0 diff
(100 %id)
T94767 lung .i-u 619 to 1013 402 to 1 I2K F3*     402/403
(99 %)
7 diff
(98.3 %id)
T92550 lung .i-u 628 to 1036 424 to 1 I2L F3N F4G S5F L6F ... fully sequenced,   424/424
(100 %)
18 diff
(95.8 %id)
T93098 lung .i-u 628 to 1034 422 to 3 I2L F3N F4G S5F L6F ...     420/422
(99 %)
0 diff
(100 %id)
T92754 lung .i-u 635 to 1003 377 to 1 I2K F3W F4X S5F L6X ...     377/377
(100 %)
10 diff
(97.4 %id)
T96396 lung .i-u 636 to 1013 391 to 1 I2*     391/391
(100 %)
20 diff
(94.9 %id)
T92917 lung .i-u 640 to 1034 405 to 3 I2K F3W F4I S5F L6X ...     403/411
(98 %)
0 diff
(100 %id)
T91522 lung .i-u 641 to 1032 402 to 1 I2K F3* fully sequenced,   402/402
(100 %)
13 diff
(96.8 %id)
T89710 lung .i-u 648 to 1036 400 to 1 I2K F3W F4I S5F L6F ... fully sequenced,   400/400
(100 %)
13 diff
(96.8 %id)
T90486 lung .i-u 654 to 1034 394 to 3 I2W F3I S5F L6S N7S ...     392/396
(98 %)
0 diff
(100 %id)
T93084 lung .i-u 656 to 1034 386 to 3 I2G F4X S5F L6P N7L ...     384/390
(98 %)
0 diff
(100 %id)
T96394 lung .i-u 657 to 1004 354 to 1 I2* fully sequenced,   354/354
(100 %)
8 diff
(97.8 %id)
T87712 lung .i-u 659 to 1034 387 to 3 I2M F3D S5F L6X N7P ...     385/411
(93 %)
0 diff
(100 %id)
T96270 lung .i-u 660 to 1034 386 to 3 I2D S5X N7L V8M L9V ...     384/386
(99 %)
0 diff
(100 %id)
T92331 lung .i-u 664 to 1024 381 to 13 I2M F3D S5F L6X N7P ... fully sequenced, AAA   369/369
(100 %)
12 diff
(96.8 %id)
T92345 lung .i-u 664 to 1036 380 to 1 I2G S5F L6P N7P V8* fully sequenced,   380/380
(100 %)
16 diff
(95.8 %id)
T94574 lung .i-u 665 to 1020 365 to 1 I2N F3G S5F L6X N7P ... fully sequenced,   365/365
(100 %)
12 diff
(96.8 %id)
T96384 lung .i-u 669 to 1013 355 to 1 I2D F3L S5X L6P N7P ...     355/355
(100 %)
13 diff
(96.4 %id)
T90508 lung .i-u 677 to 1024 368 to 13 I2D S5X L6X N7L V8M ... fully sequenced, AAA   356/356
(100 %)
12 diff
(96.7 %id)
T96162 lung .i-u 678 to 1018 354 to 2 F4X L6P N7L V8M L9Y ...     353/360
(98 %)
0 diff
(100 %id)
T94802 lung .i-u 678 to 1019 355 to 1 I2D F3X S5X L6P N7X ...     355/360
(98 %)
21 diff
(94.2 %id)
T93517 lung .i-u 687 to 1017 335 to 1   fully sequenced,   335/335
(100 %)
4 diff
(98.9 %id)
T92884.
matches multiple genes
lung .i-u 693 to 1026 344 to 11     also hits gene tatimi 334/344
(97 %)
0 diff
(100 %id)
T94786 lung .i-u 696 to 1021 326 to 1       326/326
(100 %)
0 diff
(100 %id)
T93588 lung .i-u 699 to 1034 345 to 3       343/349
(98 %)
0 diff
(100 %id)
T94774 lung .i-u 699 to 1017 320 to 1       320/322
(99 %)
1 diff
(99.7 %id)
T90310 lung .i-u 701 to 1034 342 to 3       340/345
(98 %)
0 diff
(100 %id)
T94127 lung .i-u 701 to 1012 320 to 1       320/323
(99 %)
11 diff
(96.6 %id)
T96240 lung .i-u 702 to 1034 341 to 3       339/344
(98 %)
0 diff
(100 %id)
T91727 lung .i-u 703 to 1034 335 to 3       333/335
(99 %)
0 diff
(100 %id)
T94077 lung .i-u 703 to 1014 313 to 1       313/313
(100 %)
1 diff
(99.7 %id)
T94454 lung .i-u 711 to 1018 310 to 1       310/313
(99 %)
10 diff
(96.9 %id)
T89143 lung .i-u 723 to 1036 318 to 1   fully sequenced,   318/318
(100 %)
5 diff
(98.5 %id)
T96351 lung .i-u 735 to 1034 309 to 3       307/312
(98 %)
0 diff
(100 %id)
T94375 lung .i-u 735 to 999 265 to 1       265/265
(100 %)
6 diff
(97.8 %id)
T92430 lung .i-u 738 to 1034 301 to 3       299/350
(85 %)
0 diff
(100 %id)
T92435 lung .i-u 738 to 1034 301 to 3       299/346
(86 %)
0 diff
(100 %id)
T92560 lung .i-u 738 to 1024 300 to 13   AAA   288/418
(68 %)
3 diff
(99.3 %id)
T92740 lung .i-u 738 to 1024 289 to 2       288/417
(69 %)
0 diff
(100 %id)
T94139 lung .i-u 740 to 1012 280 to 1       280/347
(80 %)
10 diff
(97.2 %id)
T96176 lung .i-u 744 to 1018 280 to 3       278/281
(98 %)
0 diff
(100 %id)
T91741 lung .i-u 754 to 1025 287 to 13   AAA   275/275
(100 %)
7 diff
(97.5 %id)
T94402 lung .i-u 773 to 1011 239 to 1       239/239
(100 %)
0 diff
(100 %id)
T96353 lung .i-u 775 to 1034 267 to 3       265/267
(99 %)
0 diff
(100 %id)
T90322 lung .i-u 777 to 1034 261 to 3       259/261
(99 %)
0 diff
(100 %id)
T90314 lung .i-u 822 to 1018 197 to 1       197/197
(100 %)
1 diff
(99.5 %id)
T92927.
matches multiple genes
lung .i-u 822 to 1022 207 to 5     also hits gene BTG1 203/207
(98 %)
0 diff
(100 %id)
N55067 liver and spleen .i-u 832 to 1258 429 to 1   tiling clone,   429/429
(100 %)
3 diff
(99.4 %id)
T89129 lung .i-u 833 to 1015 183 to 1       183/183
(100 %)
6 diff
(96.8 %id)
T92907 lung .i-u 838 to 1024 199 to 13   AAA   187/187
(100 %)
3 diff
(98.4 %id)
T93291 lung .i-u 838 to 1023 188 to 3       186/188
(98 %)
0 diff
(100 %id)
T92601 lung .i-u 850 to 1025 178 to 3       176/178
(98 %)
0 diff
(100 %id)
T93590 lung .i-u 852 to 1024 173 to 1       173/173
(100 %)
0 diff
(100 %id)
DC421946 uterus Gene RAD23B, variant not shown         Suspected internal deletion, this clone was ignored    
377 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h-u, .i-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI